Celgene's v Inrebic receives US FDA approval to treat patients with myelofibrosis

Press/Media: Press / Media

PeriodAug 19 2019

Media coverage

2

Media coverage

  • TitleCelgene's v Inrebic receives US FDA approval to treat patients with myelofibrosis
    Media name/outletPharmaBiz
    CountryIndia
    Date8/19/19
    PersonsRuben Mesa
  • TitleCelgene's v Inrebic receives US FDA approval to treat patients with myelofibrosis
    Media name/outletPharmaBiz
    CountryIndia
    Date8/19/19
    PersonsRuben Mesa